TAZ antibody (C-Term)

Catalog No. ABIN185489

The Goat Polyclonal anti-TAZ antibody has been validated for WB and ELISA. It is suitable to detect TAZ in samples from Human.

Quick Overview for TAZ antibody (C-Term) (ABIN185489)

Target: TAZ (Tafazzin (TAZ))

Reactivity: Human

Host: Goat

Clonality: Polyclonal

Conjugate: This TAZ antibody is un-conjugated

Application: Western Blotting (WB), ELISA

Grade: Verified

Product Details anti-TAZ Antibody

Binding Specificity: C-Term

Purpose: Tafazzin

Sequence: HLKTQAEQLH NH

Specificity: This antibody is expected to recognise isoforms 1to 4 (NP_000107.1, NP_851828.1, NP_851829.1, NP_851830.1, respectively).

Cross-Reactivity: Dog, Human, Mouse, Rat

Purification: Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.

Immunogen: Peptide with sequence C-HLKTQAEQLHNH, from the C Terminus of the protein sequence according to NP_000107.1, NP_851828.1, NP_851829.1, NP_851830.1.

Isotype: IgG

Application Details

Application Notes:

Western Blot: Approx 28 kDa band observed in Human Heart lysates (calculated MW of 33.5 kDa according to NP_000107.1, 30.2 kDa according to NP_851828.1, 31.7 kDa according to NP_851829.1 and 28.5 according to NP_851830.1). Recommended concentration: 0.3-1.0

Peptide ELISA: antibody detection limit dilution 1:32000.

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 0.5 mg/mL

Buffer: Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handling Advice: Minimize freezing and thawing.

Storage: -20 °C

Storage Comment: Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.

Target Details for TAZ

Target: TAZ (Tafazzin (TAZ))

Alternative Name: TAZ

Background: TAZ, tafazzin (cardiomyopathy, dilated 3A (X-linked) endocardial fibroelastosis 2 Barth syndrome) , HGNC:11577, BTHS, CMD3A, EFE, EFE2, G4.5, XAP-2 , OTTHUMP00000061673, cardiomyopathy, dilated 3A (X-linked), tafazzin, XX-FW83563B9.3, FLJ27390, Taz1, LVNC

Gene ID: 6901

NCBI Accession: NP_000107, NP_851828, NP_851829, NP_851830